Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Neurostimulation Devices Market In 2029?
The market for neurostimulation devices has seen swift expansion in the recent past. The market size, which stood at $6.3 billion in 2024, is projected to leap to $7.1 billion in 2025, registering a compound annual growth rate (CAGR) of 12.6%. Factors such as chronic pain management, an aging demographic, increased awareness, acceptance, and a multidisciplinary approach have driven this historic growth phase.
What Growth Rate Is Forecasted for the Neurostimulation Devices Market by 2029?
In the coming years, the market for neurostimulation devices is predicted to experience a swift expansion. The market size is forecasted to reach $11.18 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. This projected growth during the forecast period can be credited to the advancements in minimally invasive procedures, expansion in emerging markets, governmental regulatory support and reimbursement, as well as telehealth and remote monitoring systems. Key trends during this period are expected to include personalized treatment, the advent of wearable neurostimulation devices, progress in programming and connectivity, and combination therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2539&type=smp
Which Key Companies Are Shaping the Future of the Neurostimulation Devices Market?
Major companies operating in the neurostimulation devices market include Medtronic plc, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., Cochlear Ltd., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, DePuy Synthes Inc., Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation
Which Factors Are Driving Demand in the Neurostimulation Devices Industry?
The neurostimulation device market is experiencing growth due to the escalating elderly population worldwide. As the population ages, there is a increasing incidence of various neurobiological disorders among this demographic. For example, the World Health Organization, a United Nations agency focused on global public health, declared in October 2022 that by 2050, 80% of the elderly population will reside in low- to middle-income countries. Furthermore, from 2015 to 2050, the percentage of the global population aged 60 and above is projected to nearly double, growing from 12% to 22%.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2539&type=smp
How Is the Neurostimulation Devices Market Segmented by Several Divisions?
The neurostimulation devices market covered in this report is segmented –
1) By Product: Implantable Devices, External Devices
2) By Application: Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease
3) By End User: Hospitals, Rehabilitation Centers, Medical Clinic
Subsegments:
1) By Implantable Devices: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS)
2) By External Devices: Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Cranial Electrotherapy Stimulation (CES) Devices
What are the Emerging Market Trends Driving the Growth of the Neurostimulation Devices Industry?
Advancements in minimally invasive approaches for the management of diverse neurological diseases, are in the works. They aim to cause minimal disruption during neurological treatment through the evolution of neurostimulation gadgets. For instance, Deep Brain Stimulation (DBS) is an operative process with minimal invasion used for addressing symptoms of Parkinson’s disease like tremors, rigidity and control of movement. DBS uses a neurostimulation appliance reminiscent of a heart pacemaker, to administer electrical signals to an exact location within the brain circuits that are responsible for the symptoms of Parkinson’s disease. The electrical signals from the DBS contraption interfere with the circuit’s activity allowing the rest of the brain to function more normally.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Which Regions Are Driving Growth in the Neurostimulation Devices Market?
North America was the largest region in the global neurostimulation devices market in 2023. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2539
This Report Delivers Insight On:
1. How big is the neurostimulation devices market, and how is it changing globally?
2. Who are the major companies in the neurostimulation devices market, and how are they performing?
3. What are the key opportunities and risks in the neurostimulation devices market right now?
4. Which products or customer segments are growing the most in the neurostimulation devices market?
5. What factors are helping or slowing down the growth of the neurostimulation devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
